Format
Sort by

Send to

Choose Destination

Search results

Items: 16

1.

Exposure to high endotoxin concentration increases wheezing prevalence among laboratory animal workers: a cross-sectional study.

Freitas AS, Simoneti CS, Ferraz E, Bagatin E, Brandão IT, Silva CL, Borges MC, Vianna EO.

BMC Pulm Med. 2016 May 6;16(1):69. doi: 10.1186/s12890-016-0233-1.

2.

P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression.

Martinez CG, Zamith-Miranda D, da Silva MG, Ribeiro KC, Brandão IT, Silva CL, Diaz BL, Bellio M, Persechini PM, Kurtenbach E.

Sci Rep. 2015 Nov 23;5:16940. doi: 10.1038/srep16940.

3.

Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis.

Rodrigues RF, Zárate-Bladés CR, Rios WM, Soares LS, Souza PR, Brandão IT, Masson AP, Arnoldi FG, Ramos SG, Letourneur F, Jacques S, Cagnard N, Chiocchia G, Silva CL.

J Antimicrob Chemother. 2015;70(6):1774-83. doi: 10.1093/jac/dkv023.

4.

Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity.

Doimo NT, Zárate-Bladés CR, Rodrigues RF, Tefé-Silva C, Trotte MN, Souza PR, Soares LS, Rios WM, Floriano EM, Brandão IT, Masson AP, Coelho V, Ramos SG, Silva CL.

Hum Vaccin Immunother. 2014;10(5):1238-43. doi: 10.4161/hv.28249.

5.

Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.

Zárate-Bladés CR, Rodrigues RF, Souza PR, Rios WM, Soares LS, Rosada RS, Brandão IT, Masson AP, Floriano EM, Ramos SG, Silva CL.

Hum Vaccin Immunother. 2013 May;9(5):1093-103. doi: 10.4161/hv.23417.

6.

A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection.

dos Santos SA, Zárate-Bladés CR, de Sá Galetti FC, Brandão IT, Masson AP, Soares EG, Araújo AP, Silva CL.

Hum Vaccin. 2010 Dec;6(12):1047-53.

PMID:
21157178
7.

Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis.

Souza PR, Zárate-Bladés CR, Hori JI, Ramos SG, Lima DS, Schneider T, Rosada RS, Torre LG, Santana MH, Brandão IT, Masson AP, Coelho-Castelo AA, Bonato VL, Galetti FC, Gonçalves ED, Botte DA, Machado JB, Silva CL.

Expert Opin Biol Ther. 2008 Sep;8(9):1255-64. doi: 10.1517/14712598.8.9.1255 .

PMID:
18694348
8.

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.

Rosada RS, de la Torre LG, Frantz FG, Trombone AP, Zárate-Bladés CR, Fonseca DM, Souza PR, Brandão IT, Masson AP, Soares EG, Ramos SG, Faccioli LH, Silva CL, Santana MH, Coelho-Castelo AA.

BMC Immunol. 2008 Jul 22;9:38. doi: 10.1186/1471-2172-9-38.

9.

pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection.

Malheiro A, Aníbal FF, Martins-Filho OA, Teixeira-Carvalho A, Perini A, Martins MA, Medeiros AI, Turato WM, Acencio MP, Brandão IT, Nomizo A, Silva CL, Faccioli LH.

Vaccine. 2008 Jan 17;26(3):305-15.

PMID:
18083279
10.

Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage.

Pelizon AC, Martins DR, Zorzella SF, Trombone AP, Lorenzi JC, Carvalho RF, Brandão IT, Coelho-Castelo AA, Silva CL, Sartori A.

Genet Vaccines Ther. 2007 Nov 29;5:12.

11.

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming.

Gonçalves ED, Bonato VL, da Fonseca DM, Soares EG, Brandão IT, Soares AP, Silva CL.

Genet Vaccines Ther. 2007 Aug 22;5:7.

12.

DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice.

Giménez LE, Hernández CC, Mattos EC, Brandão IT, Olivieri B, Campelo RP, Araújo-Jorge T, Silva CL, Campos de Carvalho AC, Kurtenbach E.

J Mol Cell Cardiol. 2005 May;38(5):703-14.

PMID:
15850564
13.

Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.

Ruberti M, De Melo LK, Dos Santos SA, Brandao IT, Soares EG, Silva CL, Júnior JM.

J Drug Target. 2004 May;12(4):195-203.

PMID:
15506168
14.

Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo.

Lima KM, dos Santos SA, Santos RR, Brandão IT, Rodrigues JM Jr, Silva CL.

Vaccine. 2003 Dec 8;22(1):49-56.

PMID:
14604570
15.

Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.

Lima VM, Bonato VL, Lima KM, Dos Santos SA, Dos Santos RR, Gonçalves ED, Faccioli LH, Brandão IT, Rodrigues-Junior JM, Silva CL.

Infect Immun. 2001 Sep;69(9):5305-12.

16.

Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice.

Lima KM, Bonato VL, Faccioli LH, Brandão IT, dos Santos SA, Coelho-Castelo AA, Leão SC, Silva CL.

Vaccine. 2001 May 14;19(25-26):3518-25.

PMID:
11348719
Items per page

Supplemental Content

Loading ...
Support Center